Materiality
79.25
m&a
Source
External coverage
Decided
2026-10-20
Silence Therapeutics agreed to an acquisition by Merck KGaA, driving a sharp positive repricing in SLN; the deal remains subject to customary closing conditions. The payload’s MRK hint identifies Merck & Co., but the primary announcement names Merck KGaA, so MRK is not scored.
View event details4 more curated

